Breaking News
Quotes
All Instrument Types
  • All Instrument Types
  • Indices
  • Equities
  • ETFs
  • Funds
  • Commodities
  • Currencies
  • Crypto
  • Bonds
  • Certificates

Please try another search

Search website for: 
Popular News
More
Popular Analysis
More
More
Get 40% Off
/Free Sign Up
 0
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list
Close

IVERIC bio Inc (ISEE)

Create Alert
Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow IVERIC bio's earnings

Delivery Method

Status

Create Manage my alerts 
Back
Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
 
Create New Watchlist Create
Create a new holdings portfolio Add Create
+ Add another position Close
IVERIC bio historical data, for real-time data please try another search
39.950 +0.000    +0.00%
10/07 - Real-time Cboe. Currency in USD ( Disclaimer )
Type:  Equity
Market:  United States
  • Volume: 0
  • Bid/Ask: 0.000 / 0.000
  • Day's Range: 39.850 - 39.990
IVERIC bio 39.950 +0.000 +0.00%

ISEE Balance Sheet

 
Featured here, the Balance Sheet for IVERIC bio Inc, which summarizes the company's financial position including assets, liabilities and shareholder equity for each of the latest 4 period ending dates (either quarterly or annually).
AnnualQuarterly
InvestingPro Advanced Balance Sheet
Collapse All
Period Ending: 2023
31/03
 2022
31/12
 2022
30/09
 2022
30/06
Total Current Assets 611.54 662.83 329.48 317.22
Cash and Short Term Investments 599.92 646.84 320.54 311.96
Cash - - - -
Cash & Equivalents 467.57 476.3 153.1 141.11
Short Term Investments 132.35 170.53 167.44 170.85
Total Receivables, Net - - - -
Accounts Receivables - Trade, Net - - - -
Total Inventory - - - -
Prepaid Expenses 11.62 15.99 8.94 5.26
Other Current Assets, Total - - - -
Total Assets 613.41 666.82 331.79 319.76
Property/Plant/Equipment, Total - Net 1.86 2.13 2.31 2.53
Property/Plant/Equipment, Total - Gross - 3.26 - -
Accumulated Depreciation, Total - -1.13 - -
Goodwill, Net - - - -
Intangibles, Net - - - -
Long Term Investments - - - -
Note Receivable - Long Term - - - -
Other Long Term Assets, Total - 1.87 - -
Other Assets, Total 132.35 170.53 167.44 170.85
Total Current Liabilities 39.37 35.59 24.59 26.48
Accounts Payable 18.03 22.84 11.6 8.18
Payable/Accrued - - - -
Accrued Expenses 20.57 11.56 11.38 16.58
Notes Payable/Short Term Debt - - - -
Current Port. of LT Debt/Capital Leases 0.774 1.19 1.6 1.72
Other Current liabilities, Total - - - -
Total Liabilities 136.36 132.17 72.26 26.81
Total Long Term Debt 96.99 96.57 47.65 -
Long Term Debt 96.99 96.57 47.65 -
Capital Lease Obligations - - - -
Deferred Income Tax - - - -
Minority Interest - - - -
Other Liabilities, Total -100 -99.99 -47.62 0.331
Total Equity 477.05 534.66 259.53 292.95
Redeemable Preferred Stock, Total - - - -
Preferred Stock - Non Redeemable, Net - - - -
Common Stock, Total 0.137 0.137 0.121 0.117
Additional Paid-In Capital 1414.04 1399.56 1065.54 1056.75
Retained Earnings (Accumulated Deficit) -937.04 -864.81 -805.74 -763.39
Treasury Stock - Common - - - -
ESOP Debt Guarantee - - - -
Unrealized Gain (Loss) - - - -
Other Equity, Total -0.099 -0.229 -0.395 -0.528
Total Liabilities & Shareholders' Equity 613.41 666.82 331.79 319.76
Total Common Shares Outstanding 137.25 136.64 120.57 116.87
Total Preferred Shares Outstanding - - - -
* In Millions of USD (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on the balance sheet, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

I Agree

ISEE Comments

Write your thoughts about IVERIC bio Inc
 
Are you sure you want to delete this chart?
Delete Cancel
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
Replace Cancel
1000
Comment Guidelines
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Stonks Go up
Stonks Go up Jul 01, 2023 2:42PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Today is $39.34 but i say we hit $50 by end of August
Reply
0 0
Report
Menashe Ben Chaim
Menashe Ben Chaim Sep 11, 2021 10:47AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
over reacting , let's wait for Monday
Reply
0 2
Report
Ray Kowalsky
Ray Kowalsky Nov 05, 2019 5:34PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
If this gets to 5.00$ or above and holds there, it might look like Arrowhead Pharmaceuticals. ARWR. Any thoughts?
Reply
4 1
Report
Nison Kay
Nison Kay Nov 05, 2019 5:34PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
the treatments they are researching are very rare and R&D is very high. so I don't know how much of an earning potential they can get even if they do successful make a treatment.
Reply
1 0
Report
aa bb
aa bb Oct 31, 2019 3:12PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
wow this stock was the hottest yesterday and only the first reply in 2 years... I see other stocks / futures have very active discussions...
Reply
2 1
Report
andrew mccorkle
andrew mccorkle Oct 31, 2019 3:12PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
9
Reply
0 0
Report
daniel pierce
daniel pierce Oct 30, 2019 11:37AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
think 4.58 then 32.00 maybe
Reply
2 1
Report
Jeffrey Lafazan
DuckSoup Nov 14, 2017 6:26AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Very cool. ..back to $40?
Reply
0 0
Report
Sándor Tóth
Sándor Tóth Nov 08, 2017 10:01AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
q3 erning most important data IS total stockholders equity is POSITIV!!!!
Reply
0 0
Report
 
Are you sure you want to delete this chart?
Delete Cancel
 
Post
 
Replace the attached chart with a new chart ?
Replace Cancel
1000
Comment Guidelines
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Cancel Attach
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Confirm Block Cancel
Ok
Report this comment

I feel that this comment is:

Submit
Comment flagged

Thank You!

Your report has been sent to our moderators for review
Close
Continue with Google
or
Sign up with Email